Literature DB >> 20377760

How an age of anxiety became an age of depression.

Allan V Horwitz1.   

Abstract

CONTEXT: During the 1950s and 1960s, anxiety was the emblematic mental health problem in the United States, and depression was considered to be a rare condition. One of the most puzzling phenomena regarding mental health treatment, research, and policy is why depression has become the central component of the stress tradition since then.
METHODS: This article reviews statistical trends in diagnosis, treatment, drug prescriptions, and textual readings of diagnostic criteria and secondary literature.
FINDINGS: The association of anxiety with diffuse and amorphous conceptions of "stress" and "neuroses" became incompatible with professional norms demanding diagnostic specificity. At the same time, the contrasting nosologies of anxiety and depression in the Diagnostic and Statistical Manual of Mental Disorders III (DSM-III) extended major depressive disorder to encompass far more patients than any particular anxiety disorder. In addition, antidepressant drugs were not associated with the stigma and alleged side effects of the anxiolytic drugs.
CONCLUSION: Various factors combined between the 1970s and the 1990s to transform conditions that had been viewed as "anxiety" into "depression." New interests in the twenty-first century, however, might lead to the reemergence of anxiety as the signature mental health problem of American society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377760      PMCID: PMC2888013          DOI: 10.1111/j.1468-0009.2010.00591.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  28 in total

1.  Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.

Authors:  Samuel H Zuvekas
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Minor tranquilizers: use, misuse or overuse?

Authors:  B Blackwell
Journal:  Psychosomatics       Date:  1975       Impact factor: 2.386

Review 4.  Drug use in outpatient treatment.

Authors:  K Rickels
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

Review 5.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

Review 6.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

7.  Trends in research in two general psychiatric journals in 1969-1990: research on research.

Authors:  H A Pincus; B Henderson; D Blackwood; T Dial
Journal:  Am J Psychiatry       Date:  1993-01       Impact factor: 18.112

8.  Factors affecting the prescribing of psychotropic drugs in general practice consultations.

Authors:  N V Raynes
Journal:  Psychol Med       Date:  1979-11       Impact factor: 7.723

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 10.  Melancholia: from DSM-III to DSM-III-R.

Authors:  M Zimmerman; R L Spitzer
Journal:  Am J Psychiatry       Date:  1989-01       Impact factor: 18.112

View more
  9 in total

1.  Idioms of distress revisited.

Authors:  Mark Nichter
Journal:  Cult Med Psychiatry       Date:  2010-06

2.  Response to Suffering of the Seriously Ill Child: A History of Palliative Care for Children.

Authors:  Bryan A Sisk; Chris Feudtner; Myra Bluebond-Langner; Barbara Sourkes; Pamela S Hinds; Joanne Wolfe
Journal:  Pediatrics       Date:  2019-12-05       Impact factor: 7.124

3.  Depressive-like behavior is elevated among offspring of parents exposed to dim light at night prior to mating.

Authors:  Yasmine M Cissé; Kathryn L G Russart; Randy J Nelson
Journal:  Psychoneuroendocrinology       Date:  2017-06-12       Impact factor: 4.905

4.  Perceived symptom targets of antidepressants, anxiolytics, and sedatives: the search for modifiable factors that improve adherence.

Authors:  Melissa M Garrido; Kenneth S Boockvar
Journal:  J Behav Health Serv Res       Date:  2014-10       Impact factor: 1.505

5.  Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record users.

Authors:  Elissa R Weitzman; Skyler Kelemen; Liljana Kaci; Kenneth D Mandl
Journal:  BMC Med Inform Decis Mak       Date:  2012-05-22       Impact factor: 2.796

6.  Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice.

Authors:  Jeon-Kyung Kim; Sang-Kap Han; Min-Kyung Joo; Dong-Hyun Kim
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

7.  An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?

Authors:  Van Looy Kilian; Van de Velde Sarah
Journal:  Arch Public Health       Date:  2022-08-15

8.  Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson's Disease.

Authors:  Bowen Chang; Chen Ni; Jiaming Mei; Chi Xiong; Peng Chen; Manli Jiang; Chaoshi Niu
Journal:  Brain Sci       Date:  2022-06-28

9.  On social plasticity: the transformative power of pharmaceuticals on health, nature and identity.

Authors:  Johanne Collin
Journal:  Sociol Health Illn       Date:  2015-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.